{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:30:13Z","timestamp":1793464213212,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40261-026-01597-1","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:10:31Z","timestamp":1789830631000},"page":"1213-1237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptomatic Interventions for Allergic Rhinitis Without Comorbid Asthma: A Dose-Stratified Network Meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Sajjad","family":"Salimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Babajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Mohammadnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rezaiemanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"5","key":"1597_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.anai.2020.06.038","volume":"125","author":"K Du","year":"2020","unstructured":"Du K, Qing H, Zheng M, Wang X, Zhang L. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(5):589-96.e3. https:\/\/doi.org\/10.1016\/j.anai.2020.06.038.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"1597_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.23822\/EURANNACI.1764-1489.171","volume":"53","author":"MA Tosca","year":"2020","unstructured":"Tosca MA, Marseglia GL, Ciprandi G, Anastasio E, Brambilla I, Caffarelli C, et al. The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world \u201cControL\u2019Asma\u201d study. Eur Ann Allergy Clin Immunol. 2020;53(3):143\u20135. https:\/\/doi.org\/10.23822\/EURANNACI.1764-1489.171.","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1","key":"1597_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00227-0","volume":"6","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. https:\/\/doi.org\/10.1038\/s41572-020-00227-0.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1597_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/all.16384","volume":"80","author":"B Sousa-Pinto","year":"2025","unstructured":"Sousa-Pinto B, Vieira RJ, Bognanni A, Gil-Mata S, Ferreira-da-Silva R, Ferreira A, et al. Efficacy and safety of intranasal medications for allergic rhinitis: network meta-analysis. Allergy. 2025;80(1):94\u2013105. https:\/\/doi.org\/10.1111\/all.16384.","journal-title":"Allergy"},{"issue":"4","key":"1597_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2023.03.009","volume":"89","author":"D Hong","year":"2023","unstructured":"Hong D, Weng J, Ye M, Liu Y. Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials. Braz J Otorhinolaryngol. 2023;89(4):101272. https:\/\/doi.org\/10.1016\/j.bjorl.2023.03.009.","journal-title":"Braz J Otorhinolaryngol"},{"key":"1597_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1184552","volume":"14","author":"KK Soe","year":"2023","unstructured":"Soe KK, Krikeerati T, Pheerapanyawaranun C, Niyomnaitham S, Phinyo P, Thongngarm T. Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis. Front Pharmacol. 2023;14:1184552. https:\/\/doi.org\/10.3389\/fphar.2023.1184552.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1597_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384. https:\/\/doi.org\/10.7326\/m14-2385.","journal-title":"Ann Intern Med"},{"key":"1597_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1597_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"BMJ"},{"issue":"6","key":"1597_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","volume":"37","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020;37(6):387. https:\/\/doi.org\/10.1136\/emermed-2020-209567.","journal-title":"Emerg Med J"},{"key":"1597_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144816","volume":"14","author":"Z Ji","year":"2023","unstructured":"Ji Z, Jiang F. Efficacy and safety of sublingual immunotherapy for allergic rhinitis: a network meta-analysis. Front Immunol. 2023;14:1144816. https:\/\/doi.org\/10.3389\/fimmu.2023.1144816.","journal-title":"Front Immunol"},{"key":"1597_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9377518","author":"S Jiang","year":"2023","unstructured":"Jiang S, Xie S, Tang Q, Zhang H, Xie Z, Zhang J, et al. Evaluation of intralymphatic immunotherapy in allergic rhinitis patients: a systematic review and meta-analysis. Mediators Inflamm. 2023. https:\/\/doi.org\/10.1155\/2023\/9377518.","journal-title":"Mediators Inflamm"},{"issue":"12","key":"1597_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/nejmra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367. https:\/\/doi.org\/10.1056\/nejmra035092.","journal-title":"N Engl J Med"},{"issue":"10","key":"1597_CR14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","volume":"63","author":"H Derendorf","year":"2008","unstructured":"Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292\u2013300. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01750.x.","journal-title":"Allergy"},{"issue":"1","key":"1597_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"7","key":"1597_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","volume":"59","author":"N Buscemi","year":"2006","unstructured":"Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol. 2006;59(7):697\u2013703. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.11.010.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1597_CR17","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.jid.2016.08.021","volume":"136","author":"AM Drucker","year":"2016","unstructured":"Drucker AM, Fleming P, Chan AW. Research techniques made simple: assessing risk of bias in systematic reviews. J Investig Dermatol. 2016;136(11):e109\u201314. https:\/\/doi.org\/10.1016\/j.jid.2016.08.021.","journal-title":"J Investig Dermatol"},{"key":"1597_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074495","volume":"381","author":"A Izcovich","year":"2023","unstructured":"Izcovich A, Chu DK, Mustafa RA, Guyatt G, Brignardello-Petersen R. A guide and pragmatic considerations for applying GRADE to network meta-analysis. BMJ. 2023;381:e074495. https:\/\/doi.org\/10.1136\/bmj-2022-074495.","journal-title":"BMJ"},{"issue":"10","key":"1597_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS\u00a0One. 2013;8(10):e76654. https:\/\/doi.org\/10.1371\/journal.pone.0076654.","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"1597_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4097\/kja.21358","volume":"74","author":"E Ahn","year":"2021","unstructured":"Ahn E, Kang H. Concepts and emerging issues of network meta-analysis. Korean J Anesthesiol. 2021;74(5):371\u201382. https:\/\/doi.org\/10.4097\/kja.21358.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"1597_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.1044","volume":"3","author":"JPT Higgins","year":"2012","unstructured":"Higgins JPT, Jackson D, Barrett J, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3(2):98\u2013110. https:\/\/doi.org\/10.1002\/jrsm.1044.","journal-title":"Res Synth Methods"},{"issue":"7-8","key":"1597_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7\u20138):932\u201344. https:\/\/doi.org\/10.1002\/sim.3767.","journal-title":"Stat Med"},{"issue":"3","key":"1597_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11121-021-01289-6","volume":"23","author":"G Seitidis","year":"2022","unstructured":"Seitidis G, Nikolakopoulos S, Hennessy EA, Tanner-Smith EE, Mavridis D. Network meta-analysis techniques for synthesizing prevention science evidence. Prev Sci. 2022;23(3):415\u201324. https:\/\/doi.org\/10.1007\/s11121-021-01289-6.","journal-title":"Prev Sci"},{"key":"1597_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-35","volume":"13","author":"U Krahn","year":"2013","unstructured":"Krahn U, Binder H, K\u00f6nig J. A graphical tool for locating inconsistency in network meta-analyses. BMC Med Res Methodol. 2013;13:35. https:\/\/doi.org\/10.1186\/1471-2288-13-35.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1597_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163\u201371. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1597_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/jama.2016.21040","volume":"317","author":"GW Scadding","year":"2017","unstructured":"Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, et al. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial. JAMA. 2017;317(6):615\u201325. https:\/\/doi.org\/10.1001\/jama.2016.21040.","journal-title":"JAMA"},{"issue":"5","key":"1597_CR27","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaci.2012.01.077","volume":"129","author":"W Carr","year":"2012","unstructured":"Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129(5):1282-9.e10. https:\/\/doi.org\/10.1016\/j.jaci.2012.01.077.","journal-title":"J Allergy Clin Immunol"},{"key":"1597_CR28","doi-asserted-by":"publisher","unstructured":"Brandi V, Stahl EG. Clinical equivalence between generic and branded fluticasone propionate nasal spray in patients with allergic rhinitis. Rev Peru Med Exp Salud Publica [Internet]. 2009;26(4). https:\/\/doi.org\/10.17843\/rpmesp.2009.264.1404. https:\/\/rpmesp.ins.gob.pe\/index.php\/rpmesp\/article\/view\/1404. Accessed 24 Apr 2026.","DOI":"10.17843\/rpmesp.2009.264.1404"},{"issue":"11","key":"1597_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/alr.22197","volume":"8","author":"H Chen","year":"2018","unstructured":"Chen H, Lou H, Wang Y, Cao F, Zhang L, Wang C. Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(11):1254\u201362. https:\/\/doi.org\/10.1002\/alr.22197.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"Suppl 2","key":"1597_CR30","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1097\/01.WOX.0000411894.59771.44","volume":"5","author":"A Diaz","year":"2012","unstructured":"Diaz A. Once daily intranasal fluticasone furoate decreases daytime sleepiness and improves cognitive performance in symptomatic seasonal allergic rhinitis. World Allergy Organ J. 2012;5(Suppl 2):S66. https:\/\/doi.org\/10.1097\/01.WOX.0000411894.59771.44.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"1597_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000494507","volume":"178","author":"NI Ilyina","year":"2019","unstructured":"Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, et al. Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal allergic rhinitis: results from Russia. Int Arch Allergy Immunol. 2019;178(3):255\u201363. https:\/\/doi.org\/10.1159\/000494507.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"1597_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4168\/aair.2015.7.2.158","volume":"7","author":"CH Kim","year":"2015","unstructured":"Kim CH, Kim JK, Kim HJ, Cho JH, Kim JS, Kim YD, et al. Comparison of intranasal ciclesonide, oral levocetirizine, and combination treatment for allergic rhinitis. Allergy Asthma Immunol Res. 2015;7(2):158\u201366. https:\/\/doi.org\/10.4168\/aair.2015.7.2.158.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"1597_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/0976-500X.85958","volume":"2","author":"R Maiti","year":"2011","unstructured":"Maiti R, Jaida J, Rahman J, Gaddam R, Palani A. Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: a comparative study of efficacy and safety. J Pharmacol Pharmacother. 2011;2(4):270\u20136. https:\/\/doi.org\/10.4103\/0976-500X.85958.","journal-title":"J Pharmacol Pharmacother"},{"issue":"8","key":"1597_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/archoto.2010.128","volume":"136","author":"R Maiti","year":"2010","unstructured":"Maiti R, Rahman J, Jaida J, Allala U, Palani A. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. Arch Otolaryngol Head Neck Surg. 2010;136(8):796\u2013800. https:\/\/doi.org\/10.1001\/archoto.2010.128.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"1597_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1365-2222.2006.02478.x","volume":"36","author":"ML Barnes","year":"2006","unstructured":"Barnes ML, Ward JH, Fardon TC, Lipworth BJ. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy. 2006;36(5):676\u201384. https:\/\/doi.org\/10.1111\/j.1365-2222.2006.02478.x.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"1597_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s1081-1206(10)62057-1","volume":"91","author":"MS Dykewicz","year":"2003","unstructured":"Dykewicz MS, Kaiser HB, Nathan RA, Goode-Sellers S, Cook CK, Witham LA, et al. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Ann Allergy Asthma Immunol. 2003;91(1):44\u20138. https:\/\/doi.org\/10.1016\/s1081-1206(10)62057-1.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1597_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s1081-1206(10)63320-0","volume":"77","author":"ZM Munk","year":"1996","unstructured":"Munk ZM, LaForce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1996;77(4):277\u201381. https:\/\/doi.org\/10.1016\/s1081-1206(10)63320-0.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1597_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18203\/issn.2454-5929.ijohns20205625","volume":"7","author":"S Panchal","year":"2021","unstructured":"Panchal S, Patil S, Barkate H. Evaluation of efficacy and safety of montelukast and levocetirizine FDC tablet compared to montelukast and levocetirizine tablet in patients with seasonal allergic rhinitis: a randomized, double blind, multicentre, phase III trial. Int J Otorhinolaryngol Head Neck Surg. 2021;7:83\u201390. https:\/\/doi.org\/10.18203\/issn.2454-5929.ijohns20205625.","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"issue":"6","key":"1597_CR39","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1067\/mai.2002.124467","volume":"109","author":"T Pullerits","year":"2002","unstructured":"Pullerits T, Praks L, Ristioja V, L\u00f6tvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109(6):949\u201355. https:\/\/doi.org\/10.1067\/mai.2002.124467.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1597_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2500\/aap.2009.30.3232","volume":"30","author":"MA Kaliner","year":"2009","unstructured":"Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 \u00b5g in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(4):389\u201399. https:\/\/doi.org\/10.2500\/aap.2009.30.3232.","journal-title":"Allergy Asthma Proc"},{"key":"1597_CR41","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2013.4.0065","author":"WH Aneeza","year":"2013","unstructured":"Aneeza WH, Husain S, Rahman RA, Van Dort D, Abdullah A, Gendeh BS. Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis. Allergy Rhinol (Providence). 2013. https:\/\/doi.org\/10.2500\/ar.2013.4.0065.","journal-title":"Allergy Rhinol (Providence)"},{"issue":"6","key":"1597_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/s1081-1206(10)61894-7","volume":"88","author":"M Bende","year":"2002","unstructured":"Bende M, Carrillo T, V\u00f3na I, da Gra\u00e7a Castel-Branco M, Arheden L. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2002;88(6):617\u201323. https:\/\/doi.org\/10.1016\/s1081-1206(10)61894-7.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1597_CR43","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.waojou.2024.101021","volume":"18","author":"J Bousquet","year":"2025","unstructured":"Bousquet J, Klimek L, Kuhl HC, Nguyen DT, KumarRamalingam R, Canonica GW, et al. In perennial allergic rhinitis, RQLQ is improved similarly by azelastine 0.15% and mometasone furoate. World Allergy Organ J. 2025;18(1):100960. https:\/\/doi.org\/10.1016\/j.waojou.2024.101021.","journal-title":"World Allergy Organ J"},{"issue":"5","key":"1597_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.otohns.2010.01.016","volume":"142","author":"C Cingi","year":"2010","unstructured":"Cingi C, Ozlugedik S. Effects of montelukast on quality of life in patients with persistent allergic rhinitis. Otolaryngol Head Neck Surg. 2010;142(5):654\u20138. https:\/\/doi.org\/10.1016\/j.otohns.2010.01.016.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"1597_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2500\/ajra.2012.26.3675","volume":"26","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Rinia B, van Drunen CM, Hellings PW, Hens G, Jansen A, et al. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray. Am J Rhinol Allergy. 2012;26(1):36\u201344. https:\/\/doi.org\/10.2500\/ajra.2012.26.3675.","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"1597_CR46","first-page":"17","volume":"38","author":"N Hanprasertpong","year":"2016","unstructured":"Hanprasertpong N, Warinruk J, Fooanant S, Rojanasthein N, Roongapinun S, Arpornchayanon W, et al. Comparison of the efficacy of rupatadine with levocetirizine in patients with persistent allergic rhinitis. Thai J Pharmacol. 2016;38(2):17\u201324.","journal-title":"Thai J Pharmacol."},{"issue":"3","key":"1597_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaip.2024.12.035","volume":"13","author":"X Li","year":"2025","unstructured":"Li X, Wang X, Yang Q, Chen J, Tian H, Lu M, et al. A randomized comparison of bencycloquidium bromide, mometasone furoate, and a combination for persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2025;13(3):670-9.e3. https:\/\/doi.org\/10.1016\/j.jaip.2024.12.035.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1597_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ijporl.2008.12.025","volume":"73","author":"PH Ratner","year":"2009","unstructured":"Ratner PH, Meltzer EO, Teper A. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2009;73(5):651\u20137. https:\/\/doi.org\/10.1016\/j.ijporl.2008.12.025.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"1597_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/s0194-59980301449-9","volume":"129","author":"CJ Tai","year":"2003","unstructured":"Tai CJ, Wang PC. Comparisons of two intranasal corticosteroid preparations in treating allergic rhinitis. Otolaryngol Head Neck Surg. 2003;129(5):518\u201325. https:\/\/doi.org\/10.1016\/s0194-59980301449-9.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"1597_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2165\/00044011-199816060-00001","volume":"16","author":"RJ Davies","year":"1998","unstructured":"Davies RJ, Lund VJ, Harten-Ash VJ. The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokine mRNA expression in nasal polyps. Clin Drug Investig. 1998;16(6):413\u201320. https:\/\/doi.org\/10.2165\/00044011-199816060-00001.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"1597_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/pai.2007.002","volume":"20","author":"K Kim","year":"2007","unstructured":"Kim K, Weiswasser M, Nave R, Ratner P, Nayak A, Herron J, et al. Safety of once-daily ciclesonide nasal spray in children 2 to 5 years of age with perennial allergic rhinitis. Pediatr Asthma Allergy Immunol. 2007;20(4):229\u201342. https:\/\/doi.org\/10.1089\/pai.2007.002.","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"1597_CR52","doi-asserted-by":"publisher","unstructured":"Kowalski ML, Jurkiewicz D, Kruszewski J, Nowak D, Zietkowski Z, SSpiccAkov\u00e1\u00e1 M, et al. Rupatadine 10 and 20 mg are effective and safe in the treatment of perennial allergic rhinitis after 4 weeks of treatment: a randomized, double-blind, controlled trial with loratadine and placebo. Clin Pract. 2009;6(3):417. https:\/\/doi.org\/10.2217\/thy.09.1.","DOI":"10.2217\/thy.09.1"},{"key":"1597_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/JAA.S18265","volume":"4","author":"F Marmouz","year":"2011","unstructured":"Marmouz F, Giralt J, Izquierdo I. Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial. J Asthma Allergy. 2011;4:27\u201335. https:\/\/doi.org\/10.2147\/JAA.S18265.","journal-title":"J Asthma Allergy."},{"issue":"3","key":"1597_CR54","doi-asserted-by":"publisher","first-page":"E702","DOI":"10.1002\/lary.28906","volume":"131","author":"JH Mo","year":"2021","unstructured":"Mo JH, Jeong JH, Kim TH, Kim ST, Kim SW, Lee KH, et al. Double-blind placebo-controlled trial of bepotastine salicylate in patients with allergic rhinitis. Laryngoscope. 2021;131(3):E702\u20139. https:\/\/doi.org\/10.1002\/lary.28906.","journal-title":"Laryngoscope"},{"issue":"1","key":"1597_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s1081-1206(10)60624-2","volume":"99","author":"P Chervinsky","year":"2007","unstructured":"Chervinsky P, Kunjibettu S, Miller DL, Prenner BM, Raphael G, Hall N, et al. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007;99(1):69\u201376. https:\/\/doi.org\/10.1016\/s1081-1206(10)60624-2.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"1597_CR56","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1398-9995.2008.01668.x","volume":"63","author":"S Fantin","year":"2008","unstructured":"Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, et al. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Allergy. 2008;63(7):924\u201331. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01668.x.","journal-title":"Allergy"},{"issue":"11","key":"1597_CR57","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1398-9995.2009.02096.x","volume":"64","author":"K Holmberg","year":"2009","unstructured":"Holmberg K, Tonnel AB, Dreyfus I, Olsson P, Cougnard J, Mesbah K, et al. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy. 2009;64(11):1663\u201370. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02096.x.","journal-title":"Allergy"},{"key":"1597_CR58","doi-asserted-by":"publisher","unstructured":"Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; 2007). Clin Exp Allergy. 2017;47(7):856\u201389. https:\/\/doi.org\/10.1111\/cea.12953.","DOI":"10.1111\/cea.12953"},{"issue":"4","key":"1597_CR59","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","volume":"140","author":"JL Bro\u017cek","year":"2016","unstructured":"Bro\u017cek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines\u20142016 revision. J Allergy Clin Immunol. 2016;140(4):950\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"1597_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tao.2021.suppl.1","volume":"59","author":"MC Ecevit","year":"2021","unstructured":"Ecevit MC, \u00d6zcan M, Can \u0130H, Tatar E\u00c7, \u00d6zer S, Esen E, et al. Turkish guideline for diagnosis and treatment of allergic rhinitis (ART). Turk Arch Otorhinolaryngol. 2021;59(Suppl 1):1\u2013157. https:\/\/doi.org\/10.4274\/tao.2021.suppl.1.","journal-title":"Turk Arch Otorhinolaryngol."},{"key":"1597_CR61","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2147\/jaa.s374346","volume":"15","author":"B Abdullah","year":"2022","unstructured":"Abdullah B, Abdul Latiff AH, Manuel AM, Mohamed Jamli F, Dalip Singh HS, Ismail IH, et al. Pharmacological management of allergic rhinitis: a consensus statement from the Malaysian Society of Allergy and Immunology. J Asthma Allergy. 2022;15:983\u20131003. https:\/\/doi.org\/10.2147\/jaa.s374346.","journal-title":"J Asthma Allergy"},{"issue":"1","key":"1597_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4168\/aair.2023.15.1.19","volume":"15","author":"SI Yang","year":"2023","unstructured":"Yang SI, Lee IH, Kim M, Ryu G, Kang SY, Kim MA, et al. KAAACI allergic rhinitis guidelines: part 1. Update in pharmacotherapy. Allergy Asthma Immunol Res. 2023;15(1):19\u201342. https:\/\/doi.org\/10.4168\/aair.2023.15.1.19.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1 Suppl","key":"1597_CR63","doi-asserted-by":"publisher","first-page":"S1-43","DOI":"10.1177\/0194599814561600","volume":"152","author":"MD Seidman","year":"2015","unstructured":"Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1 Suppl):S1\u201343. https:\/\/doi.org\/10.1177\/0194599814561600.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1597_CR64","doi-asserted-by":"publisher","unstructured":"Queralt M, Merlos M, Giral M, Puigdemont A. Dual effect of a new compound, rupatadine, on edema induced by platelet-activating factor and histamine in dogs: comparison with antihistamines and PAF antagonists. Drug Dev Res. 1996;39(1):12\u20138. https:\/\/doi.org\/10.1002\/(SICI)1098-2299(19960901)39:1<12::AID-DDR2>3.0.CO;2-N.","DOI":"10.1002\/(SICI)1098-2299(19960901)39:1<12::AID-DDR2>3.0.CO;2-N"},{"issue":"2","key":"1597_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5415\/apallergy.2012.2.2.115","volume":"2","author":"T Tamura","year":"2012","unstructured":"Tamura T. Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models. Asia Pac Allergy. 2012;2(2):115\u201321. https:\/\/doi.org\/10.5415\/apallergy.2012.2.2.115.","journal-title":"Asia Pac Allergy"},{"key":"1597_CR66","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2147\/jaa.s321332","volume":"14","author":"PT Daley-Yates","year":"2021","unstructured":"Daley-Yates PT, Larenas-Linnemann D, Bhargave C, Verma M. Intranasal corticosteroids: topical potency, systemic activity and therapeutic index. J Asthma Allergy. 2021;14:1093\u2013104. https:\/\/doi.org\/10.2147\/jaa.s321332.","journal-title":"J Asthma Allergy"},{"issue":"Suppl 3","key":"1597_CR67","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/s0924-977x(03)00097-x","volume":"13","author":"SP Roose","year":"2003","unstructured":"Roose SP. Compliance: the impact of adverse events and tolerability on the physician\u2019s treatment decisions. Eur Neuropsychopharmacol. 2003;13(Suppl 3):S85-92. https:\/\/doi.org\/10.1016\/s0924-977x(03)00097-x.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"1597_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233\u201347. https:\/\/doi.org\/10.1038\/nri.2017.1.","journal-title":"Nat Rev Immunol"},{"key":"1597_CR69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4193\/RHINOL\/20.070","volume":"3","author":"S Treat","year":"2020","unstructured":"Treat S, Ebert CS Jr, Farzal Z, Basu S, Zanation AM, Thorp BD, et al. Intranasal corticosteroids: patient administration angles and impact of education. Rhinol Online. 2020;3:160\u20136. https:\/\/doi.org\/10.4193\/RHINOL\/20.070.","journal-title":"Rhinol Online."},{"issue":"1","key":"1597_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0194599819832277","volume":"161","author":"EL Wu","year":"2019","unstructured":"Wu EL, Harris WC, Babcock CM, Alexander BH, Riley CA, McCoul ED. Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161(1):18\u201327. https:\/\/doi.org\/10.1177\/0194599819832277.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"1597_CR71","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1017\/s0022215117002080","volume":"131","author":"V Ganesh","year":"2017","unstructured":"Ganesh V, Banigo A, McMurran AEL, Shakeel M, Ram B. Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey. J Laryngol Otol. 2017;131(11):991\u20136. https:\/\/doi.org\/10.1017\/s0022215117002080.","journal-title":"J Laryngol Otol"},{"issue":"1","key":"1597_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-020-00480-z","volume":"50","author":"J Fowler","year":"2021","unstructured":"Fowler J, Rotenberg BW, Sowerby LJ. The subtle nuances of intranasal corticosteroids. J Otolaryngol Head Neck Surg. 2021;50(1):18. https:\/\/doi.org\/10.1186\/s40463-020-00480-z.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"3","key":"1597_CR73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1370\/afm.1338","volume":"10","author":"G Hayward","year":"2012","unstructured":"Hayward G, Heneghan C, Perera R, Thompson M. Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med. 2012;10(3):241\u20139. https:\/\/doi.org\/10.1370\/afm.1338.","journal-title":"Ann Fam Med"},{"key":"1597_CR74","doi-asserted-by":"publisher","unstructured":"Taylor-Clark T. Histamine in allergic rhinitis. In: Histamine in Inflammation. 2010. p. 33-41. https:\/\/doi.org\/10.1007\/978-1-4419-8056-4_4.","DOI":"10.1007\/978-1-4419-8056-4_4"},{"issue":"1","key":"1597_CR75","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1513\/pats.201008-057rn","volume":"8","author":"B Sin","year":"2011","unstructured":"Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc. 2011;8(1):106\u201314. https:\/\/doi.org\/10.1513\/pats.201008-057rn.","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"1597_CR76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0394632015600598","volume":"28","author":"K Pa\u0142gan","year":"2015","unstructured":"Pa\u0142gan K, Bartuzi Z. Platelet activating factor in allergies. Int J Immunopathol Pharmacol. 2015;28(4):584\u20139. https:\/\/doi.org\/10.1177\/0394632015600598.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"7","key":"1597_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0628-3","volume":"16","author":"E Schauberger","year":"2016","unstructured":"Schauberger E, Peinhaupt M, Cazares T, Lindsley AW. Lipid mediators of allergic disease: pathways, treatments, and emerging therapeutic targets. Curr Allergy Asthma Rep. 2016;16(7):48. https:\/\/doi.org\/10.1007\/s11882-016-0628-3.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"1597_CR78","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/alr.23578","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang Z, Wang C, Zhang L. Efficacy and safety of combined pharmacotherapies in moderate-to-severe allergic rhinitis: a network meta-analysis. Int Forum Allergy Rhinol. 2025;15(3):312\u201325. https:\/\/doi.org\/10.1002\/alr.23578.","journal-title":"Int Forum Allergy Rhinol."},{"issue":"1","key":"1597_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","volume":"145","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Sch\u00fcnemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. https:\/\/doi.org\/10.1016\/j.jaci.2019.06.049.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1597_CR80","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","volume":"79","author":"HK Batchelor","year":"2015","unstructured":"Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 2015;79(3):395\u2013404. https:\/\/doi.org\/10.1111\/bcp.12267.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"1597_CR81","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/alr.23015","volume":"12","author":"W Chitsuthipakorn","year":"2022","unstructured":"Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. Combined medical therapy in the treatment of allergic rhinitis: systematic review and meta-analyses. Int Forum Allergy Rhinol. 2022;12(12):1480\u2013502. https:\/\/doi.org\/10.1002\/alr.23015.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"17","key":"1597_CR82","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s40265-020-01406-9","volume":"80","author":"M Krishnamoorthy","year":"2020","unstructured":"Krishnamoorthy M, Mohd Noor N, Mat Lazim N, Abdullah B. Efficacy of montelukast in allergic rhinitis treatment: a systematic review and meta-analysis. Drugs. 2020;80(17):1831\u201351. https:\/\/doi.org\/10.1007\/s40265-020-01406-9.","journal-title":"Drugs"},{"issue":"2","key":"1597_CR83","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.2500\/ajra.2011.25.3604","volume":"25","author":"MA Lung","year":"2011","unstructured":"Lung MA. M1 and M3 muscarinic receptors mediate relaxation and contraction in canine nasal veins. Am J Rhinol Allergy. 2011;25(2):e60\u20135. https:\/\/doi.org\/10.2500\/ajra.2011.25.3604.","journal-title":"Am J Rhinol Allergy"},{"issue":"11","key":"1597_CR84","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00405-020-06183-5","volume":"277","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Xiao H, Liu S, He G, Hu G, Zhang X, et al. Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial. Eur Arch Otorhinolaryngol. 2020;277(11):3067\u201377. https:\/\/doi.org\/10.1007\/s00405-020-06183-5.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1597_CR85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41533-024-00408-4","volume":"35","author":"E Tameeris","year":"2025","unstructured":"Tameeris E, Bohnen AM, Bindels PJE, Elshout G. The effect of allergic rhinitis treatment on asthma control: a systematic review. NPJ Prim Care Respir Med. 2025;35(1):4. https:\/\/doi.org\/10.1038\/s41533-024-00408-4.","journal-title":"NPJ Prim Care Respir Med."},{"issue":"10","key":"1597_CR86","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.jaip.2025.07.004","volume":"13","author":"S Gil-Mata","year":"2025","unstructured":"Gil-Mata S, Vieira RJ, Borowiack E, Sadowska E, Bognanni A, Cardoso-Fernandes A, et al. Intranasal treatments for allergic rhinitis in preschool- and school-age children: network meta-analysis. J Allergy Clin Immunol Pract. 2025;13(10):2826\u201337. https:\/\/doi.org\/10.1016\/j.jaip.2025.07.004.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1597_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1670372","volume":"16","author":"Q Hu","year":"2025","unstructured":"Hu Q, Kong L, Zhou Y, Shen W, Sun Y, Deng J. Efficacy of different nasal irrigation treatments versus placebo in allergic rhinitis: a systematic review and network meta-analysis. Front Pharmacol. 2025;16:1670372. https:\/\/doi.org\/10.3389\/fphar.2025.1670372.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1597_CR88","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4168\/aair.2025.17.6.692","volume":"17","author":"JS Kim","year":"2025","unstructured":"Kim JS, Stybayeva G, Hwang SH. Efficacy of a combination therapy of montelukast and antihistamines in allergic rhinitis: a systematic review and network meta-analysis. Allergy Asthma Immunol Res. 2025;17(6):692\u2013708. https:\/\/doi.org\/10.4168\/aair.2025.17.6.692.","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01597-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:39:50Z","timestamp":1793461190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01597-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01597-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data generated or analyzed during this study are included in this published article and its supplementary information files. The datasets are derived from publicly available primary studies cited in the references.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The statistical code used for network meta-analysis in Stata MP17 is available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.S. and A.R. conceptualized the study and developed the methodology. S.S., A.R., and A.H. conducted the literature search, investigation, and screening. S.S. and M.M.B. performed the formal statistical analysis using Stata MP17. A.M. and A.H. were responsible for data curation and validation. S.S. wrote the original draft of the manuscript, and S.S. and A.R. reviewed and edited the manuscript. S.S. and A.R. supervised the project, and S.S. was responsible for project administration. All authors read and approved the final version of the manuscript and agree to be accountable for the work.","order":7,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}